Among these surface molecules, ASGP-R, TfR, AF20 antigen, SSTR, and LAPTM4B are unsatisfactory for diagnosing HCC but may be useful therapeutic targets. The gene discussed is TFRC; the disease is hepatocellular carcinoma.